Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 1500
Single User License Price INR 107850
Corporate User License Price USD 4500
Corporate User License Price INR 323550
Site License Price USD 3000
Site License Price INR 215700
Request a Quote

Report Title

Ensemble Therapeutics Corporation-Product Pipeline Review-2016

Quote Request for License Type
License Type Price  
Single User License USD 1500
Site License USD 3000
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Ensemble Therapeutics Corporation-Product Pipeline Review-2016


Quote Request for License Type
License Type Price  
Single User License USD 1500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Ensemble Therapeutics Corporation-Product Pipeline Review-2016

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Ensemble Therapeutics Corporation-Product Pipeline Review-2016



Executive Summary

Ensemble Therapeutics Corporation-Product Pipeline Review-2016

Summary

Global Markets Direct's, Ensemble Therapeutics Corporation-Product Pipeline Review-2016', provides an overview of the Ensemble Therapeutics Corporation's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ensemble Therapeutics Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Ensemble Therapeutics Corporation

The report provides overview of Ensemble Therapeutics Corporation including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Ensemble Therapeutics Corporation's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Ensemble Therapeutics Corporation's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

Evaluate Ensemble Therapeutics Corporation's strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Ensemble Therapeutics Corporation

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Ensemble Therapeutics Corporation's pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Ensemble Therapeutics Corporation Snapshot 5

Ensemble Therapeutics Corporation Overview 5

Key Information 5

Key Facts 5

Ensemble Therapeutics Corporation-Research and Development Overview 6

Key Therapeutic Areas 6

Ensemble Therapeutics Corporation-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Pipeline Products-Out-Licensed Products 12

Out-Licensed Products/Combination Treatment Modalities 13

Ensemble Therapeutics Corporation-Pipeline Products Glance 14

Ensemble Therapeutics Corporation-Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

Ensemble Therapeutics Corporation-Drug Profiles 16

Small Molecules to Inhibit Cyclophilin A for Hepatitis B 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Small Molecules to Inhibit Cyclophilin D for Cardiovascular and Central Nervous System 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Small Molecules to Inhibit IAP for Oncology 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Small Molecules to Inhibit USP9X for Metastatic Cancer 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Small Molecules to Inhibit PCSK9 for Cardiovascular Disease 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Small Molecules to Inhibit USP28 for Oncology 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Small Molecules to Inhibit USP30 for Oncology and Parkinson's disease 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Ensemble Therapeutics Corporation-Pipeline Analysis 23

Ensemble Therapeutics Corporation-Pipeline Products by Target 23

Ensemble Therapeutics Corporation-Pipeline Products by Route of Administration 24

Ensemble Therapeutics Corporation-Pipeline Products by Molecule Type 25

Ensemble Therapeutics Corporation-Pipeline Products by Mechanism of Action 26

Ensemble Therapeutics Corporation-Dormant Projects 27

Ensemble Therapeutics Corporation-Locations And Subsidiaries 28

Head Office 28

Appendix 29

Methodology 29

Coverage 29

Secondary Research 29

Primary Research 29

Expert Panel Validation 29

Contact Us 29

Disclaimer 30

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Tables

Ensemble Therapeutics Corporation, Key Information 5

Ensemble Therapeutics Corporation, Key Facts 5

Ensemble Therapeutics Corporation-Pipeline by Indication, 2016 7

Ensemble Therapeutics Corporation-Pipeline by Stage of Development, 2016 8

Ensemble Therapeutics Corporation-Monotherapy Products in Pipeline, 2016 9

Ensemble Therapeutics Corporation-Partnered Products in Pipeline, 2016 10

Ensemble Therapeutics Corporation-Partnered Products/ Combination Treatment Modalities, 2016 11

Ensemble Therapeutics Corporation-Out-Licensed Products in Pipeline, 2016 12

Ensemble Therapeutics Corporation-Out-Licensed Products/ Combination Treatment Modalities, 2016 13

Ensemble Therapeutics Corporation-Preclinical, 2016 14

Ensemble Therapeutics Corporation-Discovery, 2016 15

Ensemble Therapeutics Corporation-Pipeline by Target, 2016 23

Ensemble Therapeutics Corporation-Pipeline by Route of Administration, 2016 24

Ensemble Therapeutics Corporation-Pipeline by Molecule Type, 2016 25

Ensemble Therapeutics Corporation-Pipeline Products by Mechanism of Action, 2016 26

Ensemble Therapeutics Corporation-Dormant Developmental Projects,2016 27

List of Figures

Ensemble Therapeutics Corporation-Pipeline by Top 10 Indication, 2016 7

Ensemble Therapeutics Corporation-Pipeline by Stage of Development, 2016 8

Ensemble Therapeutics Corporation-Monotherapy Products in Pipeline, 2016 9

Ensemble Therapeutics Corporation-Partnered Products in Pipeline, 2016 10

Ensemble Therapeutics Corporation-Out-Licensed Products in Pipeline, 2016 12

Ensemble Therapeutics Corporation-Pipeline by Target, 2016 23

Ensemble Therapeutics Corporation-Pipeline by Molecule Type, 2016 25

Ensemble Therapeutics Corporation-Pipeline Products by Mechanism of Action, 2016 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Current R&D Portfolio of Ensemble Therapeutics Corporation; Ensemble Therapeutics Corporation-Key Therapeutics; Ensemble Therapeutics Corporation-Pipeline Overview and Promising Molecules; Ensemble Therapeutics Corporation-News; Ensemble Therapeutics Corporation-Latest Updates; Ensemble Therapeutics Corporation-Pipeline; Ensemble Therapeutics Corporation-Discontinued/Dormant Projects


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand